Maternus-Kliniken Aktiengesellschaft/€MAK
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Maternus-Kliniken Aktiengesellschaft
Maternus-Kliniken Aktiengesellschaft operates within the healthcare industry, primarily focusing on providing services in rehabilitation and nursing care. The company manages clinics and nursing facilities primarily located in Germany, offering a range of rehabilitation programs, geriatric care, and specialized services for individuals requiring long-term care and support. Headquartered in Berlin, Germany, Maternus-Kliniken has established its presence across various parts of the country. The company emphasizes comprehensive patient care and has built a network of facilities aimed at delivering tailored healthcare solutions. It aligns its services to meet the growing demand for quality rehabilitation and elderly care within the region.
Ticker
€MAK
Sector
Primary listing
XETRA
Industry
Health Care Providers & Services
Headquarters
Employees
1,452
ISIN
DE0006044001
Website
MAK Metrics
BasicAdvanced
€29M
-
-€0.33
0.68
-
Price and volume
Market cap
€29M
Beta
0.68
52-week high
€1.65
52-week low
€1.28
Financial strength
Current ratio
0.292
Quick ratio
0.2
Long term debt to equity
-235.623
Total debt to equity
-235.623
Interest coverage (TTM)
-0.19%
Profitability
EBITDA (TTM)
2.013
Gross margin (TTM)
16.88%
Net profit margin (TTM)
-6.33%
Operating margin (TTM)
-1.38%
Effective tax rate (TTM)
-31.44%
Revenue per employee (TTM)
€70,000
Management effectiveness
Return on assets (TTM)
-0.61%
Return on equity (TTM)
14.03%
Valuation
Price to revenue (TTM)
0.263
Price to book
-0.52
Price to tangible book (TTM)
-0.42
Price to free cash flow (TTM)
2.18
Free cash flow yield (TTM)
45.88%
Free cash flow per share (TTM)
63.32%
Growth
Revenue change (TTM)
6.08%
Earnings per share change (TTM)
-62.60%
3-year revenue growth (CAGR)
-2.03%
10-year revenue growth (CAGR)
-0.79%
3-year earnings per share growth (CAGR)
-0.49%
10-year earnings per share growth (CAGR)
-4.01%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Maternus-Kliniken Aktiengesellschaft stock?
Maternus-Kliniken Aktiengesellschaft (MAK) has a market cap of €29M as of July 04, 2025.
What is the P/E ratio for Maternus-Kliniken Aktiengesellschaft stock?
The price to earnings (P/E) ratio for Maternus-Kliniken Aktiengesellschaft (MAK) stock is 0 as of July 04, 2025.
Does Maternus-Kliniken Aktiengesellschaft stock pay dividends?
No, Maternus-Kliniken Aktiengesellschaft (MAK) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Maternus-Kliniken Aktiengesellschaft dividend payment date?
Maternus-Kliniken Aktiengesellschaft (MAK) stock does not pay dividends to its shareholders.
What is the beta indicator for Maternus-Kliniken Aktiengesellschaft?
Maternus-Kliniken Aktiengesellschaft (MAK) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.